Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Recent developments in anti-rheumatic drugs in pediatrics: Treatment of juvenile idiopathic arthritis
Arthritis Research & Therapy, 02/26/09
Hayward K et al. – Article summarizes recent developments in the medical treatment of children with juvenile idiopathic arthritis (JIA) and offer insights into emerging therapies. Advances in the understanding of the immune system have shed light on pathways involved in inflammation and self tolerance that provide new targets for treatment of rheumatologic conditions. Biologic agents have been designed to target key cytokines implicated in JIA, including TNF-α, IL-1, IL-6 as well as signaling molecules involved in the regulation of B-cell and T-cell lymphocyte responses. Although promising results have been demonstrated with these medications, the blockade of such important biologic pathways necessitates careful safety monitoring for infection risks, responses to vaccinations, possible neurologic side effects and long-term effects on immune surveillance and possible risks of malignancy.
Related Articles
Monitoring methotrexate toxicity in juvenile idiopathic arthritis
Journal of Rheumatology, 11/19/09
Relevance Score: 90%
B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients
Arthritis & Rheumatism, 11/04/09
Relevance Score: 89%
Phenotypic and functional characterization of switch memory B cells from patients with oligoarticular juvenile idiopathic arthritis
Arthritis Research & Therapy, 10/06/09
Relevance Score: 89%
Increased frequency of extremely skewed X chromosome inactivation in juvenile idiopathic arthritis
Arthritis & Rheumatism, 11/09/09
Relevance Score: 87%
Systemic JIA: new developments in the understanding of the pathophysiology and therapy
Best Practice & Research: Clinical Rheumatology, 10/28/09
Relevance Score: 85%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: A prospective study
Osteoporosis International, 11/25/09
Treatment of osteoporosis: Recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity
Osteoporosis International, 11/25/09
Urinary deoxypyridinoline is a BMD-independent marker for prevalent vertebral fractures in postmenopausal women treated with glucocorticoid
Osteoporosis International, 11/25/09
Today in Pediatric Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Plasma level of myeloperoxidase in children with juvenile idiopathic arthritis (a pilot study)
Central European Journal of Medicine, 11/25/09
The detection of subclinical synovitis by ultrasound in oligoarticular juvenile idiopathic arthritis: A pilot study
Rheumatology, 11/24/09
Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study
Rheumatology, 11/23/09
Sponsor
Article Search
Sponsor


See Latest Articles


